The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeps Regulatory News (CEPS)

Share Price Information for Ceps (CEPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 15.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 5.00 (33.333%)
Open: 17.50
High: 17.50
Low: 17.50
Prev. Close: 17.50
CEPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pension scheme and general trading update

13 Jun 2022 10:58

RNS Number : 6544O
CEPS PLC
13 June 2022
 

13 June 2022

CEPS PLC

 ("CEPS" or the "Company")

 

Pension scheme and general trading update

 

Pension Scheme

Further to the announcement on 13 December 2021 when CEPS announced that the Trustees of the Company's defined benefit scheme (Dinkie Heel plc Retirement Benefits Scheme (the "Scheme")) had entered into a buy-in contract with Aviva, the Scheme is now being formally wound-up with effect from 1 June 2022.

 

It is expected that the Scheme will have money left over once the final balancing premium is paid to Aviva after the Scheme has completed a process to verify the amounts payable to members and dependants. This process should be complete within the next 12 months. The amount the Trustees expect to be left over is in the order of £700,000 (the "Surplus") although it may be more or less than that. In accordance with the formal rules of the Scheme, it is the intention of the Trustees to pay the Surplus to CEPS, as the employer for the Scheme, after deducting the required amount of tax, currently expected to be 35%. This would make the net amount receivable £455,000.

 

Historically, the actuarial surplus on the Scheme has not been recognised in the Company's accounts as the Company does not have an unconditional right to refunds of surpluses arising in the Scheme. Consequently, the payment of the Surplus to CEPS will have a positive impact on the Company's balance sheet when it is received.

 

Trading Update

As the Company is holding its AGM at 11.30 today, it is useful to provide a trading update for the first four months of the financial year to 30 April 2022. The Board of CEPS is pleased that all segments are performing ahead of budgeted expectations at this point in the year.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

The Directors of the Company accept responsibility for the content of this announcement.

 

Enquiries

 

CEPS PLC

Vivien Langford, Group Finance Director

 

+44 1225 483030

 

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson / Ludovico Lazzaretti

 

+44 20 7213 0880

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANKDFSXAEEA
Date   Source Headline
18th Apr 20243:46 pmRNSHolding(s) in Company
18th Apr 20247:00 amRNSPension Scheme Update
20th Mar 20244:20 pmRNSResult of General Meeting
18th Mar 20247:00 amRNSConcert Party Update
1st Mar 20247:00 amRNSProposed Share Capital Reduction and Notice of AGM
5th Feb 20247:00 amRNSTrading Update
3rd Jan 20244:30 pmRNSHolding(s) in Company
28th Nov 20234:06 pmRNSChelverton Growth Trust Update
8th Nov 20232:15 pmRNSShare Price Movement
19th Oct 20233:46 pmRNSVale Brothers - associate company corporate update
11th Oct 20237:00 amRNSVale Brothers - associate company corporate update
27th Sep 20233:48 pmRNSVale Brothers - associate company corporate update
5th Sep 20237:00 amRNSHalf-year Report
12th Jun 20232:31 pmRNSResult of AGM
5th May 20237:00 amRNSFinal Results and Notice of AGM
21st Mar 20235:29 pmRNSDirector's dealings
29th Sep 20227:00 amRNSHalf-year Report
13th Jun 202212:01 pmRNSResult of AGM
13th Jun 202210:58 amRNSPension scheme and general trading update
10th May 20227:00 amRNSFinal Results
3rd May 20227:00 amRNSExtension of existing related party loan
12th Apr 20229:34 amRNSBusiness and Assets Purchase by Aford Awards Ltd
13th Dec 20213:00 pmRNSPension Scheme, Loan Extension & Trading Update
30th Sep 20215:32 pmRNSHolding(s) in Company
30th Sep 20217:00 amRNSTotal Voting Rights
28th Sep 20213:15 pmRNSHolding(s) in Company
28th Sep 20213:13 pmRNSHolding(s) in Company
28th Sep 20212:55 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSResult of Placing
16th Sep 20214:35 pmRNSProposed Placing, Directors' Dealings & RPTs
16th Sep 20214:35 pmRNSHalf-year Report
3rd Sep 20217:00 amRNSBusiness and Assets Purchases by Aford Awards Ltd
29th Jun 20212:27 pmRNSFundraise by Hickton Group Ltd
22nd Jun 202112:11 pmRNSResult of AGM
25th May 20217:00 amRNSFinal Results
20th May 20211:54 pmRNSThird party loan and related party transaction
20th Apr 20211:10 pmRNSInterims 2020 correction
15th Apr 20212:22 pmRNSHickton Group Limited - CBIL
15th Mar 20213:53 pmRNSAcquisition of Millington Lord Limited
1st Mar 20217:05 amRNSProgressive publishes new research
25th Jan 20216:27 pmRNSDirector's dealings
22nd Jan 20217:00 amRNSRelated Party Transaction
23rd Dec 202012:21 pmRNSDirector's dealings
18th Dec 20209:18 amRNSMerger of Davies Odell with Vale Brothers
5th Nov 202010:30 amRNSRelated Party Transaction
1st Oct 20207:00 amRNSAford Awards Limited
25th Sep 20207:00 amRNSHalf-year Report
28th Aug 20207:00 amRNSRelated Party Transaction
18th Aug 20201:51 pmRNSRelated Party Transactions
23rd Jun 202012:59 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.